FDA approves highly concentrated liquid morphine for severe pain

In good news for cancer patients at the end of life,  the Food and Drug Administration has approved a concentrated liquid morphine to relieve acute and chronic pain in patients where other opiates are no longer working. Although concentrated doses of liquid morphine have used to manage pain for opiate-tolerant patients for some time, the oral…  Read More

Colorectal Cancer News in Brief: April 17

This week we have research reports about risk of complications after hand-assisted laparoscopic colectomies, the benefit of music therapy during hospice treatment, and a gene that predicts better response to cetuximab. In other headlines, we found an excellent overview of the progress made in colorectal cancer treatment with data and references.  In addition, there is information…  Read More